190 related articles for article (PubMed ID: 8115417)
1. Perceptual masking of the chlordiazepoxide discriminative cue by both caffeine and buspirone.
Gauvin DV; Peirce JM; Holloway FA
Pharmacol Biochem Behav; 1994 Jan; 47(1):153-9. PubMed ID: 8115417
[TBL] [Abstract][Full Text] [Related]
2. The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity.
Rijnders HJ; Slangen JL
Psychopharmacology (Berl); 1993; 111(1):55-61. PubMed ID: 7870934
[TBL] [Abstract][Full Text] [Related]
3. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
Oliveto AH; Bickel WK; Hughes JR; Higgins ST; Badger G
Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
[TBL] [Abstract][Full Text] [Related]
4. Methylxanthine discrimination in the rat: possible benzodiazepine and adenosine mechanisms.
Holloway FA; Modrow HE; Michaelis RC
Pharmacol Biochem Behav; 1985 May; 22(5):815-24. PubMed ID: 2989946
[TBL] [Abstract][Full Text] [Related]
5. Effects of chlordiazepoxide training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure.
De Vry J; Slangen JL
Psychopharmacology (Berl); 1986; 88(2):177-83. PubMed ID: 3006110
[TBL] [Abstract][Full Text] [Related]
6. Buspirone fails to affect the discriminative stimulus effects of cocaine.
Rapoza D
Pharmacol Biochem Behav; 1993 May; 45(1):179-83. PubMed ID: 8516356
[TBL] [Abstract][Full Text] [Related]
7. Cue dimensionality in the three-choice pentylenetetrazole-saline-chlordiazepoxide discrimination task.
Gauvin DV; Holloway FA
Behav Pharmacol; 1991 Nov; 2(4 And 5):417-428. PubMed ID: 11224084
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists.
Callahan PM; Cunningham KA
Neuropharmacology; 1997 Mar; 36(3):373-81. PubMed ID: 9175616
[TBL] [Abstract][Full Text] [Related]
9. Drug discrimination training with low doses: maintenance of discriminative control.
Tomie A; Shultz PL; Spicer MS; Peoples LL
Pharmacol Biochem Behav; 1995 Jan; 50(1):115-9. PubMed ID: 7700946
[TBL] [Abstract][Full Text] [Related]
10. The chlordiazepoxide/pentylenetetrazol discrimination: characterization of drug interactions and homeostatic responses to drug challenges.
Michaelis RC; Holohean AM; Criado JR; Harland RD; Hunter GA; Holloway FA
Psychopharmacology (Berl); 1988; 96(1):15-20. PubMed ID: 3147473
[TBL] [Abstract][Full Text] [Related]
11. Evidence for PTZ-like cues as a function of time following treatment with chlordiazepoxide: implications for understanding tolerance and withdrawal.
Barrett RJ; Smith RL
Behav Pharmacol; 2005 May; 16(3):147-53. PubMed ID: 15864069
[TBL] [Abstract][Full Text] [Related]
12. Stimulus properties of nicotine, amphetamine, and chlordiazepoxide as positive features in a pavlovian appetitive discrimination task in rats.
Palmatier MI; Wilkinson JL; Metschke DM; Bevins RA
Neuropsychopharmacology; 2005 Apr; 30(4):731-41. PubMed ID: 15592350
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of buspirone and chlordiazepoxide on successive discrimination.
Panickar KS; McNaughton N
Pharmacol Biochem Behav; 1991 Jun; 39(2):275-8. PubMed ID: 1946569
[TBL] [Abstract][Full Text] [Related]
14. Prenatal protein malnutrition enhances stimulus control by CDP, but not a CDP/THIP combination in rats.
Shultz PL; Galler JR; Tonkiss J
Pharmacol Biochem Behav; 2002 Nov; 73(4):759-67. PubMed ID: 12213520
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat.
Broersen LM; Abbate F; Feenstra MG; de Bruin JP; Heinsbroek RP; Olivier B
Psychopharmacology (Berl); 2000 May; 149(4):366-76. PubMed ID: 10867964
[TBL] [Abstract][Full Text] [Related]
16. Differential interactions between chlordiazepoxide, pentobarbital and benzodiazepine antagonists Ro 15-1788 and CGS 8216 in a drug discrimination procedure.
De Vry J; Slangen JL
Pharmacol Biochem Behav; 1986 Apr; 24(4):999-1005. PubMed ID: 3012604
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus properties of a new anxiolytic, DN-2327, in rats.
Wada T; Fukuda N
Psychopharmacology (Berl); 1993; 110(3):280-6. PubMed ID: 7831420
[TBL] [Abstract][Full Text] [Related]
18. Behavioural and pharmacological dissociation of chlordiazepoxide effects on discrimination and punished responding.
Hodges H; Baum S; Taylor P; Green S
Psychopharmacology (Berl); 1986; 89(2):155-61. PubMed ID: 3088630
[TBL] [Abstract][Full Text] [Related]
19. Effects of propranolol, buspirone, pCPA, reserpine, and chlordiazepoxide on open-field behavior.
Angrini M; Leslie JC; Shephard RA
Pharmacol Biochem Behav; 1998 Feb; 59(2):387-97. PubMed ID: 9476986
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
